Media resources/ Information Center
Media resources
Visit the Novartis.com Newsroom for our media releases.
Novartis corporate press kit ›
Find all the information you need to know about Novartis, including NIBR, in one convenient electronic press kit.
Visit the Novartis multimedia library to view and download photos, images and videos.
For media inquiries, please email us at
nibr.communications@novartis.com
Information Center
Find more information about R&D at Novartis, research strategy and working at NIBR below - download brochures, view videos and read stories.
 |
R&D at Novartis - bringing innovative medicines to patients. Novartis in Massachussetts - a global healthcare company committed to Massachusetts. Drug Discovery Process |
 |
Overview of the Novartis Institutes for BioMedical Research explaining our approach to research, our strategy in facing challenges, our commitment to collaborations, and our progress towards the future. Novartis Institutes for Tropical Diseases -discovering novel treatments and prevention methods for major tropical diseases. Novartis Vaccines Institute for Global Health -Creating affordable vaccines for neglected diseases. Imaging at Novartis - using imaging technologies to gain new insights into biological processes. High Throughput Screening - testing hundreds of thousands of compounds against a disease target to find new medicines. From Sweets to Science: Transforming an almost 80-year old former candy factory into a state-of-the-art laboratory. The Computer-Aided Drug Design (CADD) group replicates chemical interactions and properties onto computers. Helios - high throughput screening informatics architecture that helps NIBR researchers share information around world. |
 |
Proof-of-Concept strategy - The ultimate objective of Novartis R&D is to bring more and better new medicines to market in the shortest possible time. Pathways to success: finding single drugs to treat multiple diseases More Than Skin Deep - An antibody drug could change the way we treat psoriasis. Muckle-Wells and Beyond - Learn how we are treating patients who are in desperate need of options and finding new treatments for similar diseases. |
 |
Biologics at Novartis - In the past few years, biologics have become increasingly important to Novartis, comprising a full quarter of its drug pipeline. siRNA Therapeutics at Novartis R&D - Scientists at Novartis are ushering in a new era in medicine as they explore the potential of siRNA therapeutics. |
 |
Biomarkers at Novartis - To identify the basis for different patient responses to therapies, Novartis has an extensive program of biomarker discovery to pinpoint patients suitable for a given therapy; verify initial response; and monitor subsequent therapy and possible disease progression. |
 |
At Novartis Institutes for BioMedical Research, we are committed to hiring the best physicians and scientists from academia, biotech, and pharmaceuticals, who seek to work in an atmosphere where patients come first and innovation is rewarded. |
 |
At Novartis, Lab Design is focused on creating state-of-the-art laboratories comprising flexible work spaces, modular furniture to meet changing team needs, and cutting edge technology to support communication, interdisciplinary collaboration, and enhanced innovation in Novartis research. |
Current Collaborations
About us
Our global research efforts begin and end with the patient.
Learn more about our approach, people, locations and work in the community
